Abstract:Background Interferons (IFNs) are essential for activating an effective immune response and play a central role in immunotherapy-mediated immune cell reactivation for tumor regression. Type III IFN (λ), related to type I IFN (α), plays a crucial role in infections, autoimmunity, and cancer. However, the direct effects of IFN-λ on the tumor immune microenvironment have not been thoroughly investigated. Methods We used mouse MB49 bladder tumor models, constructed a retroviral vector expressing mouse IFN-λ3, and transduced tumor cells to evaluate the antitumor action of IFN-λ3 in immune-proficient tumors and T cell-deficient tumors. Furthermore, human bladder cancer samples (cohort 1, n=15) were used for immunohistochemistry and multiplex immunoflurescence analysis to assess the expression pattern of IFN-λ3 in human bladder cancer and correlate it with immune cells’ infiltration. Immunohistochemistry analysis was performed in neoadjuvant immunotherapy cohort (cohort 2, n=20) to assess the correlation between IFN-λ3 expression and the pathological complete response rate. Results In immune-proficient tumors, ectopic Ifnl3 expression in tumor cells significantly increased the infiltration of cytotoxic CD8 + T cells, Th1 cells, natural killer cells, proinflammatory macrophages, and dendritic cells, but reduced neutrophil infiltration. Transcriptomic analyses revealed significant upregulation of many genes associated with effective immune response, including lymphocyte recruitment, activation, and phagocytosis, consistent with increased antitumor immune infiltrates and tumor inhibition. Furthermore, IFN-λ3 activity sensitized immune-proficient tumors to anti-PD-1/PD-L1 blockade. In T cell-deficient tumors, increased Ly6G – Ly6C + I-A/I-E + macrophages still enhanced tumor cell phagocytosis in Ifnl3 overexpressing tumors. IFN-λ3 is expressed by tumor and stromal cells in human bladder cancer, and high IFN-λ3 expression was positively associated with effector immune infiltrates and the efficacy of immune checkpoint blockade therapy. Conclusions Our study indicated that IFN-λ3 enables macrophage-mediated phagocytosis and antitumor immune responses and suggests a rationale for using Type III IFN as a predictive biomarker and potential immunotherapeutic candidate for bladder cancer.

IFN-λ Inhibits Drug-Resistant HIV Infection of Macrophages

A 79-GHz LTCC RF-frontend for short-range applications

Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages

Comparison of antiviral activity of lambda-interferons against HIV replication in macrophages

Ether sensitivity of some mammalian pox viruses.

Interferon Epsilon Protects Primary Macrophages Against HIV Infection

Activation of NRF2 Blocks HIV Replication and Apoptosis in Macrophages

IFN-ε Protects Primary Macrophages Against HIV Infection.

A Chip Performing Chaotic Stream Encryption

Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes

Targeting type I interferon–mediated activation restores immune function in chronic HIV infection

HIV-1 but not SIVmac239 induces higher interferon-α antiviral state in chronic infected northern pig-tailed macaques (Macaca leonina)

Type III Interferons, IL-28 and IL-29, Are Increased in Chronic HCV Infection and Induce Myeloid Dendritic Cell-Mediated FoxP3+ Regulatory T Cells.

Targeting IFN-λ: therapeutic implications

IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFN

Type III interferon inhibits bladder cancer progression by reprogramming macrophage-mediated phagocytosis and orchestrating effective immune responses

Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation

HIV-1 Downregulates the Expression and Phosphorylation of Receptor Tyrosine Kinase by Targeting the NF-κB Pathway

Human Intestinal Epithelial Cells Release Antiviral Factors That Inhibit HIV Infection of Macrophages

International Journal of Computer Mathematics Numerical Solution and Spectrum of Boundary-domain Integral Equation for the Neumann Bvp with a Variable Coefficient Numerical Solution and Spectrum of Boundary-domain Integral Equation for the Neumann Bvp with a Variable Coefficient

Low Specificity of the Third Generation Elisa for HCV Detection in Voluntary Blood Donors in India